Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46,377,939
-
Number of holders
-
135
-
Total 13F shares, excl. options
-
22,346,694
-
Shares change
-
+401,759
-
Total reported value, excl. options
-
$411,905,913
-
Value change
-
+$7,350,529
-
Number of buys
-
71
-
Number of sells
-
-67
-
Price
-
$18.42
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q4 2016
157 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q4 2016.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 135 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22,346,694 shares
of 46,377,939 outstanding shares and own 48.18% of the company stock.
Largest 10 shareholders include BlackRock Fund Advisors (3,900,323 shares), VANGUARD GROUP INC (2,171,020 shares), ACADIAN ASSET MANAGEMENT LLC (1,502,151 shares), FEDERATED INVESTORS INC /PA/ (1,344,684 shares), FMR LLC (1,317,541 shares), STATE STREET CORP (955,991 shares), BlackRock Institutional Trust Company, N.A. (908,921 shares), DIMENSIONAL FUND ADVISORS LP (800,900 shares), TEACHERS ADVISORS, LLC (542,953 shares), and JPMORGAN CHASE & CO (512,773 shares).
This table shows the top 135 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.